Millstone Evans Group LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Millstone Evans Group LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 712 shares of the healthcare conglomerate's stock, valued at approximately $360,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group in the third quarter valued at $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $629.32.

Remove Ads

UnitedHealth Group Trading Up 0.9 %

NYSE UNH traded up $4.67 during trading hours on Wednesday, hitting $518.10. 3,253,715 shares of the company's stock were exchanged, compared to its average volume of 4,082,722. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business's 50 day moving average is $509.10 and its 200-day moving average is $545.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $473.92 billion, a P/E ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. The business's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.